140 related articles for article (PubMed ID: 2068134)
1. Loss of heterozygosity on chromosome 14 in neuroblastoma.
Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
[No Abstract] [Full Text] [Related]
2. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
3. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
[TBL] [Abstract][Full Text] [Related]
4. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
5. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
Srivatsan ES; Murali V; Seeger RC
Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
[TBL] [Abstract][Full Text] [Related]
7. Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma.
Theobald M; Christiansen H; Schmidt A; Melekian B; Wolkewitz N; Christiansen NM; Brinkschmidt C; Berthold F; Lampert F
Genes Chromosomes Cancer; 1999 Sep; 26(1):40-6. PubMed ID: 10441004
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
Suzuki T; Yokota J; Mugishima H; Okabe I; Ookuni M; Sugimura T; Terada M
Cancer Res; 1989 Mar; 49(5):1095-8. PubMed ID: 2563671
[TBL] [Abstract][Full Text] [Related]
9. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
11. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N
Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
[TBL] [Abstract][Full Text] [Related]
12. Is there a neuroblastoma anti-oncogene?
Schwab M
Prog Clin Biol Res; 1991; 366():1-9. PubMed ID: 2068129
[No Abstract] [Full Text] [Related]
13. Inverse expression of MYCN and mdr-1 in human neuroblastoma.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Kuwano M
Prog Clin Biol Res; 1991; 366():11-9. PubMed ID: 2068131
[No Abstract] [Full Text] [Related]
14. Genetic alterations involving chromosome 1p in children with neuroblastoma.
Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
16. High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Sharon B; Kennett RH; Rosen ST
Prog Clin Biol Res; 1991; 366():21-7. PubMed ID: 2068139
[No Abstract] [Full Text] [Related]
17. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
[TBL] [Abstract][Full Text] [Related]
18. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
19. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.
Hoshi M; Otagiri N; Shiwaku HO; Asakawa S; Shimizu N; Kaneko Y; Ohi R; Hayashi Y; Horii A
Br J Cancer; 2000 Jun; 82(11):1801-7. PubMed ID: 10839294
[TBL] [Abstract][Full Text] [Related]
20. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.
Christiansen H; Delattre O; Fuchs S; Theobald M; Christiansen NM; Berthold F; Lampert F
Prog Clin Biol Res; 1994; 385():19-25. PubMed ID: 7972212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
